Chronic Obstructive Pulmonary Disease Clinical Trial
Official title:
Right Ventricular Hemodynamics Using Cardiac Magnetic Resonance Imaging in Patients With Chronic Obstructive Pulmonary Disease (COPD) and Obstructive Sleep Apnea (OSA)
The coexistence of chronic obstructive pulmonary disease (COPD) and obstructive sleep apnea
(OSA) in the same patient has been termed overlap syndrome, affecting 1% of the U.S.
population.The investigators propose to conduct this study that aims: (1) to compare right
and left ventricular hemodynamic parameters using cardiac magnetic resonance imaging (MRI) in
overlap syndrome vs. COPD only and OSA only; (2) to compare the effects of bi-level positive
airway pressure (BPAP) vs. nocturnal oxygen therapy (NOT) on right ventricular (RV)
hemodynamics in overlap syndrome.
This study will allow us to test the hypothesis: (1) Patients with overlap syndrome have more
RV dysfunction than those with COPD only or OSA only; (2) treatment of both hypoxemia and
hypercapnia during sleep will improve RV hemodynamics compared with treatment of hypoxemia
alone in patients with overlap syndrome.
Despite the high prevalence of overlap syndrome, few data are available on its
pathophysiology and clinical consequences of these patients. Overlap syndrome has recently
been reported to have excess cardiovascular mortality compared with COPD alone. However, no
study has evaluated the mechanisms of excess cardiovascular mortality in untreated overlap
syndrome. In addition, no prospective, randomized, controlled data are currently available on
treatment of overlap syndrome.
This study is divided into two parts. The first part (Part 1) is a cross-sectional cohort
study comparing subjects with overlap syndrome to those with COPD alone and those with OSA
alone. Patients with COPD and OSA overlap syndrome will be evaluated by an overnight sleep
study, cardiac MRI, serum inflammatory biomarker, urine catecholamine level, pulmonary
function test, and questionnaires of sleep and health related quality of life. These
measurement will be compared between overlap syndrome and control groups with either COPD or
OSA alone.
The second part (Part 2) of the study is a prospective, parallel-group, randomized,
controlled pilot study examining the effect of BPAP (and nocturnal oxygen if needed) vs.
nocturnal oxygen therapy alone in patients with overlap syndrome (20 subjects in each
treatment arm). The same measurement done during Part 1 will be repeated to evaluate the
treatment effects.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05102305 -
A Multi-center,Prospective, OS to Evaluate the Effectiveness of 'NAC' Nebulizer Therapy in COPD (NEWEST)
|
||
Completed |
NCT01867762 -
An Effectiveness and Safety Study of Inhaled JNJ 49095397 (RV568) in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Recruiting |
NCT05562037 -
Stepped Care vs Center-based Cardiopulmonary Rehabilitation for Older Frail Adults Living in Rural MA
|
N/A | |
Terminated |
NCT04921332 -
Bright Light Therapy for Depression Symptoms in Adults With Cystic Fibrosis (CF) and COPD
|
N/A | |
Completed |
NCT03089515 -
Small Airway Chronic Obstructive Disease Syndrome Following Exposure to WTC Dust
|
N/A | |
Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
Recruiting |
NCT05552833 -
Pulmonary Adaptive Responses to HIIT in COPD
|
N/A | |
Recruiting |
NCT05835492 -
A Pragmatic Real-world Multicentre Observational Research Study to Explore the Clinical and Health Economic Impact of myCOPD
|
||
Recruiting |
NCT05631132 -
May Noninvasive Mechanical Ventilation (NIV) and/or Continuous Positive Airway Pressure (CPAP) Increase the Bronchoalveolar Lavage (BAL) Salvage in Patients With Pulmonary Diseases?
|
N/A | |
Completed |
NCT03244137 -
Effects of Pulmonary Rehabilitation on Cognitive Function in Patients With Severe to Very Severe Chronic Obstructive Pulmonary Disease
|
||
Not yet recruiting |
NCT03282526 -
Volume Parameters vs Flow Parameters in Assessment of Reversibility in Chronic Obstructive Pulmonary Disease
|
N/A | |
Completed |
NCT02546700 -
A Study to Evaluate Safety and Efficacy of Lebrikizumab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 2 | |
Withdrawn |
NCT04446637 -
Acute Bronchodilator Effects of Ipratropium/Levosalbutamol 20/50 mcg Fixed Dose Combination vs Salbutamol 100 mcg Inhaler Plus Ipratropium 20 mcg Inhalation Aerosol Free Combination in Patients With Stable COPD
|
Phase 3 | |
Completed |
NCT04535986 -
A Phase 3 Clinical Trial to Evaluate the Safety and Efficacy of Ensifentrine in Patients With COPD
|
Phase 3 | |
Recruiting |
NCT05865184 -
Evaluation of Home-based Sensor System to Detect Health Decompensation in Elderly Patients With History of CHF or COPD
|
||
Completed |
NCT03256695 -
Evaluate the Relationship Between Use of Albuterol Multidose Dry Powder Inhaler With an eModule (eMDPI) and Exacerbations in Participants With Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 3 | |
Completed |
NCT03295474 -
Telemonitoring in Pulmonary Rehabilitation: Feasibility and Acceptability of a Remote Pulse Oxymetry System.
|
||
Withdrawn |
NCT04042168 -
Implications of Appropriate Use of Inhalers in Chronic Obstructive Pulmonary Disease (COPD)
|
Phase 4 | |
Completed |
NCT03414541 -
Safety And Efficacy Study Of Orally Administered DS102 In Patients With Chronic Obstructive Pulmonary Disease
|
Phase 2 | |
Completed |
NCT02552160 -
DETECT-Register DocumEnTation and Evaluation of a COPD Combination Therapy
|